Lance Palmer

Title: Lance Palmer: Innovator in HCV Detection Technologies

Introduction

Lance Palmer is a notable inventor based in Collierville, TN (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of Hepatitis C virus (HCV). With a total of 5 patents to his name, Palmer's work has advanced the methodologies used in viral detection.

Latest Patents

Palmer's latest patents focus on reagents and methods for detecting HCV. The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, specifically in regions that encode the NS3 polypeptide. In some embodiments, the primers are utilized in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.

Career Highlights

Throughout his career, Lance Palmer has worked with prominent companies in the healthcare sector, including Siemens Healthcare Diagnostics GmbH and Siemens Corporation. His experience in these organizations has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Palmer has collaborated with various professionals in his field, including Arejas Uzgiris and Sunil Pandit. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Lance Palmer's contributions to the field of HCV detection exemplify the impact of innovation in medical diagnostics. His patents and collaborations reflect a commitment to improving healthcare outcomes through advanced technology.